Coherus BioSciences, Inc. (CHRS) Analyst Forecast

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.8
Day's range
$1.95

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
04/24/2025 UBS Ashwani Verma $1.05 $1.05   0.48%
12/05/2024 Robert W. Baird Colleen Kusy $6.00 $1.74   245.82%
06/13/2022 UBS Ashwani Verma $7.00 $6.19   13.09%

Coherus Oncology Inc. FAQ's

Coherus Oncology Inc. has been rated by research analysts at UBS, Robert W. Baird, J.P. Morgan in the past 90 days.